Bevacizumab in Neoadjuvant Chemotherapy Increases the Pathological Complete Response Rate in Patients With Triple-Negative Breast Cancer

被引：14
|
作者：
Barton, Mary Kay
机构：
来源：
CA-A CANCER JOURNAL FOR CLINICIANS | 2014年 / 64卷 / 03期
关键词：
D O I：
10.3322/caac.21223
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [1] Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Nakashoji, Ayako
    Matsui, Akira
    Nagayama, Aiko
    Iwata, Yuko
    Sasahara, Manami
    Murata, Yuya
    [J]. ONCOLOGY LETTERS, 2017, 14 (04) : 4135 - 4141
  • [2] A preliminary study on predicting pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Chen, Xi
    Zhou, Zhiguo
    [J]. CANCER RESEARCH, 2024, 84 (03)
  • [3] Prognostic function of Ki-67 for pathological complete response rate of neoadjuvant chemotherapy in triple-negative breast cancer
    Zhang, Guojing
    Xie, Wanqing
    Liu, Zhaozhe
    Lin, Chao
    Piao, Ying
    Xu, Long
    Guo, Fang
    Xie, Xiaodong
    [J]. TUMORI JOURNAL, 2014, 100 (02): : 136 - 142
  • [4] Pathological Complete Response with Platinum Containing Neoadjuvant Chemotherapy in Triple-negative Breast Cancer: An Interventional Study
    Jose, Binila mary
    Kumar, V. R. Ajith
    Meloot, Suma Susan
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (04) : XC1 - XC4
  • [5] Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
    Gass, Paul
    Lux, Michael P.
    Rauh, Claudia
    Hein, Alexander
    Bani, Mayada R.
    Fiessler, Cornelia
    Hartmann, Arndt
    Haeberle, Lothar
    Pretscher, Jutta
    Erber, Ramona
    Wachter, David L.
    Schulz-Wendtland, Ruediger
    Beckmann, Matthias W.
    Fasching, Peter A.
    Wunderle, Marius
    [J]. BMC CANCER, 2018, 18
  • [6] Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
    Paul Gass
    Michael P. Lux
    Claudia Rauh
    Alexander Hein
    Mayada R. Bani
    Cornelia Fiessler
    Arndt Hartmann
    Lothar Häberle
    Jutta Pretscher
    Ramona Erber
    David L. Wachter
    Rüdiger Schulz-Wendtland
    Matthias W. Beckmann
    Peter A. Fasching
    Marius Wunderle
    [J]. BMC Cancer, 18
  • [7] Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy
    Toss, Angela
    Venturelli, Marta
    Civallero, Monica
    Piombino, Claudia
    Domati, Federica
    Ficarra, Guido
    Combi, Francesca
    Cabitza, Eleonora
    Caggia, Federica
    Barbieri, Elena
    Barbolini, Monica
    Moscetti, Luca
    Omarini, Claudia
    Piacentini, Federico
    Tazzioli, Giovanni
    Dominici, Massimo
    Cortesi, Laura
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).
    Krivorotko, Petr
    Zhiltsova, Elena
    Gigolaeva, Larisa
    Emelyanov, Alexander
    Pesotskiy, Roman
    Yerechshenko, Sergey
    Nikolaev, Kirill
    Komyahov, Alexander
    Ivanova, Olga
    Tabagua, Tengiz
    Zernov, Konstantin
    Ivanov, Vadim
    Aseeva, Zalina
    Bessonov, Alexander
    Semiglazov, Vladimir
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer
    Yi Yin
    Pin Zhang
    Bing-he Xu
    Bai-lin Zhang
    Qing Li
    Peng Yuan
    Rui-gang Cai
    Jia-yu Wang
    Xiang Wang
    Xiao-zhou Xu
    [J]. Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, 33 : 262 - 265
  • [10] Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer
    Yin, Yi
    Zhang, Pin
    Xu, Bing-he
    Zhang, Bai-lin
    Li, Qing
    Yuan, Peng
    Cai, Rui-gang
    Wang, Jia-yu
    Wang, Xiang
    Xu, Xiao-zhou
    [J]. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (02) : 262 - 265
12345